Source: FinanzNachrichten

ERT: ERT and Bioclinica become Clario, The Leading Technology Solutions Company for Clinical Trial Innovation and Evidence

PHILADELPHIA, Nov. 3, 2021 /PRNewswire/ -- ERT, the global clinical endpoint technology leader, today announced that following its early Q2 merger with Bioclinica, a technological and scientific l...

Read full article »
Est. Annual Revenue
$500M-1.0B
Est. Employees
1.0-5.0K
Joe Eazor's photo - President & CEO of ERT

President & CEO

Joe Eazor

CEO Approval Rating

83/100

Read more